Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Fresenius Kabi Launches Generic Epinephrine Injection in U.S. | Contract Pharma

What are you searching for?

Sign in
Breaking News

Fresenius Kabi Launches Generic Epinephrine Injection in U.S.

Demonstrates its commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Fresenius Kabi’s Epinephrine Injection, USP, is now available in the United States as the first generic version of Epinephrine in a 1mg/1mL vial for U.S. customers.
 
Epinephrine Injection, USP is a prescription medicine used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock; for emergency treatment of allergic reactions, including anaphylaxis; and for induction and maintenance of mydriasis during intraocular surgery.
 
“Fresenius Kabi is pleased to offer Epinephrine Injection to our U.S. customers, further demonstrating our continued commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve in line with #FutureFresenius,” said Arunesh Verma, president, Fresenius Kabi Region U.S. and Member, Executive Leadership Team, Fresenius Kabi AG.
 
Fresenius Kabi has invested nearly $1 billion to expand and update its U.S. pharmaceutical production and distribution facilities. Fresenius Kabi is committed to domestic production. More than 70 percent of the product units Fresenius ships in the U.S. are drugs listed on the FDA’s Essential Medicines List.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters